Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/803"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1861"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:Evidence_value	"0.2"
?:content	""In clinical pharmacology studies in man, peak plasma concentrations of rosuvastatin were reached 3 to 5 hours following oral dosing. Both peak concentration (Cmax) and area under the plasma concentration-time curve (AUC) increased in approximate proportion to rosuvastatin dose. The absolute bioavailability of rosuvastatin is approximately 20%""
dc:creator	"boycer"
dc:date	"09/28/2007 07:57:12"
rdfs:seeAlso	?:drugInfo.cfm?id=3249

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ rosuvastatin_bioavailability_continuous_value, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1861 }

Context graph